Cutera (NASDAQ:CUTR – Get Rating) was downgraded by analysts at William Blair from an “outperform” rating to a “market perform” rating in a research note issued on Thursday, The Fly reports. CUTR has been the subject of a number of other reports. StockNews.com initiated coverage on Cutera in a research note on Thursday, March 16th. […]
Cutera (NASDAQ:CUTR – Get Rating) issued its quarterly earnings data on Tuesday. The medical device company reported ($1.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.96), Briefing.com reports. The business had revenue of $55.00 million during the quarter, compared to the consensus estimate of $59.80 million. Cutera had […]
Cutera, Inc. (NASDAQ:CUTR – Get Rating) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 4,450,000 shares, a decrease of 13.9% from the March 31st total of 5,170,000 shares. Based on an average daily trading volume, of 660,300 shares, the days-to-cover ratio is […]
Shares of Cutera, Inc. (NASDAQ:CUTR – Get Rating) have been given a consensus recommendation of “Hold” by the seven research firms that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and two have given a buy recommendation to […]
Emerald Advisers LLC trimmed its position in shares of Cutera, Inc. (NASDAQ:CUTR – Get Rating) by 29.4% during the 4th quarter, HoldingsChannel.com reports. The firm owned 337,182 shares of the medical device company’s stock after selling 140,651 shares during the quarter. Emerald Advisers LLC’s holdings in Cutera were worth $14,910,000 at the end of the […]